AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,810 | +21.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $7,270 | -26.9% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $9,940 | +1.2% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $9,819 | +138.7% | 1,000 | 0.0% | 0.01% | +100.0% |
| Q4 2022 | $4,114 | -41.2% | 1,000 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $7,000 | -30.0% | 1,000 | 0.0% | 0.01% | -28.6% |
| Q2 2022 | $10,000 | +42.9% | 1,000 | +233.3% | 0.01% | +40.0% |
| Q3 2021 | $7,000 | -86.0% | 300 | -92.4% | 0.01% | -86.8% |
| Q2 2021 | $50,000 | +6.4% | 3,950 | +8.2% | 0.04% | -2.6% |
| Q1 2021 | $47,000 | +34.3% | 3,650 | +37.7% | 0.04% | +14.7% |
| Q4 2020 | $35,000 | -10.3% | 2,650 | 0.0% | 0.03% | -19.0% |
| Q3 2020 | $39,000 | -2.5% | 2,650 | 0.0% | 0.04% | -4.5% |
| Q2 2020 | $40,000 | +5.3% | 2,650 | 0.0% | 0.04% | -6.4% |
| Q1 2020 | $38,000 | -7.3% | 2,650 | +30.9% | 0.05% | +17.5% |
| Q4 2019 | $41,000 | – | 2,025 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |